HCPCS Service Codes - Medical care

HCPCS Codes for Medical care

• A2001

  Innovamatrix ac, per square centimeter

• A2002

  Mirragen advanced wound matrix, per square centimeter

• A2004

  Xcellistem, 1 mg

• A2005

  Microlyte matrix, per square centimeter

• A2006

  Novosorb synpath dermal matrix, per square centimeter

• A2007

  Restrata, per square centimeter

• A2008

  Theragenesis, per square centimeter

• A2009

  Symphony, per square centimeter

• A2010

  Apis, per square centimeter

• A2011

  Supra sdrm, per square centimeter

• A2012

  Suprathel, per square centimeter

• A2013

  Innovamatrix fs, per square centimeter

• A2014

  Omeza collagen matrix, per 100 mg

• A2015

  Phoenix wound matrix, per square centimeter

• A2016

  Permeaderm b, per square centimeter

• A2017

  Permeaderm glove, each

• A2018

  Permeaderm c, per square centimeter

• A4100

  Skin substitute, fda cleared as a device, not otherwise specified

• A4216

  Sterile water, saline and/or dextrose, diluent/flush, 10 ml

• A4217

  Sterile water/saline, 500 ml

• A4218

  Sterile saline or water, metered dose dispenser, 10 ml

• A9581

  Injection, gadoxetate disodium, 1 ml

• C7900

  Service for diagnosis, evaluation, or treatment of a mental health or substance use disorder, initial 15-29 minutes, provided remotely by hospital staff who are licensed to provide mental health services under applicable state law(s), when the patient is in their home, and there is no associated professional service

• C7901

  Service for diagnosis, evaluation, or treatment of a mental health or substance use disorder, initial 30-60 minutes, provided remotely by hospital staff who are licensed to provided mental health services under applicable state law(s), when the patient is in their home, and there is no associated professional service

• C7902

  Service for diagnosis, evaluation, or treatment of a mental health or substance use disorder, each additional 15 minutes, provided remotely by hospital staff who are licensed to provide mental health services under applicable state law(s), when the patient is in their home, and there is no associated professional service (list separately in addition to code for primary service)

• C8957

  Intravenous infusion for therapy/diagnosis; initiation of prolonged infusion (more than 8 hours), requiring use of portable or implantable pump

• C9094

  Inj, sutimlimab-jome, 10 mg

• C9095

  Inj, tebentafusp-tebn, 1 mcg

• C9096

  Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram

• C9097

  Inj, faricimab-svoa, 0.1 mg

• C9098

  Ciltacabtagene autoleucel, up to 100 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose

• C9101

  Injection, oliceridine, 0.1 mg

• C9121

  Injection, argatroban, per 5 mg

• C9132

  Prothrombin complex concentrate (human), kcentra, per i.u. of factor ix activity

• C9142

  Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg

• C9248

  Injection, clevidipine butyrate, 1 mg

• C9285

  Lidocaine 70 mg/tetracaine 70 mg, per patch

• C9290

  Injection, bupivacaine liposome, 1 mg

• C9293

  Injection, glucarpidase, 10 units

• C9399

  Unclassified drugs or biologicals

• C9460

  Injection, cangrelor, 1 mg

• C9738

  Adjunctive blue light cystoscopy with fluorescent imaging agent (list separately in addition to code for primary procedure)

• C9757

  Laminotomy (hemilaminectomy), with decompression of nerve root(s), including partial facetectomy, foraminotomy and excision of herniated intervertebral disc, and repair of annular defect with implantation of bone anchored annular closure device, including annular defect measurement, alignment and sizing assessment, and image guidance; 1 interspace, lumbar

• C9800

  Dermal injection procedure(s) for facial lipodystrophy syndrome (lds) and provision of radiesse or sculptra dermal filler, including all items and supplies

• C9898

  Radiolabeled product provided during a hospital inpatient stay

• C9899

  Implanted prosthetic device, payable only for inpatients who do not have inpatient coverage

• G0010

  Administration of hepatitis b vaccine

• G0028

  Documentation of medical reason(s) for not screening for tobacco use (e.g., limited life expectancy, other medical reason)

• G0029

  Tobacco screening not performed or tobacco cessation intervention not provided during the measurement period or in the six months prior to the measurement period

• G0030

  Patient screened for tobacco use and received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling, pharmacotherapy, or both), if identified as a tobacco user